NexImmune, Inc.
NEXI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $2,330 | $5,851 | $105,241 | $576,454 |
| - Cash | $3,202 | $34,642 | $30,326 | $5,031 |
| + Debt | $69 | $1,025 | $0 | $19,118 |
| Enterprise Value | -$804 | -$27,766 | $74,915 | $590,541 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,025 | -$1,495 | -$870 | -$619 |
| % Margin | – | – | – | – |
| EBITDA | -$28,168 | -$61,011 | -$49,126 | -$27,564 |
| % Margin | – | – | – | – |
| Net Income | -$32,344 | $514,184 | -$51,745 | -$31,639 |
| % Margin | – | – | – | – |
| EPS Diluted | -30.82 | 534.29 | -56.67 | -34.76 |
| % Growth | -105.8% | 1,042.8% | -63% | – |
| Operating Cash Flow | -$31,430 | -$51,191 | -$45,785 | -$26,405 |
| Capital Expenditures | -$49 | -$1,255 | -$2,350 | -$865 |
| Free Cash Flow | -$31,479 | -$52,446 | -$48,135 | -$27,269 |